Skip to main content

Table 1 Biochemical profile, treatment, and dietary regimen of OTC deficient patients in Family 1 and Family 2

From: Father-to-daughter transmission in late-onset OTC deficiency: an underestimated mechanism of inheritance of an X-linked disease

 

Sex

Age

(years)

Symptoms

Blood ammonia

(n.v.<50 µmol/L)

Plasma glutamine

(n.v. 200–800 µmol/L)

Plasma citrulline

(n.v. 10–35 µmol/L)

Plasma arginine

(n.v. 30–90 µmol/L)

Urinary orotic acid

(0.1–10 mol/mmol creat)

Therapy

Protein

restricted diet

 

Family 1

II-1

M

73

migraine, irritabilty

22

714

18

47

0.5

arginine

yes

III-1

F

43

coma, death

805

1295

21

63

208

no

no

III-4

F

27

nausea, migraine, irritabilty

22

712

28

43

0.5

arginine

yes

III-6

F

29

nausea, migraine, irritabilty

22

603

10

22

0.3

arginine

yes

 

Family 2

II-5

M

74

confusion, abnormal behaviour

76

1279

14

50

3.0

arginine,

GPB

yes

III- 1

F

58

no

6

674

25

74

not available

no

no

III-2

F

56

no

7.7

790

36

45

not available

no

no

III-4

F

51

migraine

26

806

24

54

0.8

arginine

yes

III-8

F

50

migraine, vomiting

26

876

26

48

0.4

arginine

yes

IV-2

F

31

no

14

753

29

84

not available

no

no

IV-3

F

31

no

13

658

13

34

not available

no

no

IV-4

F

23

no

22

787

26

80

not available

no

no

V-3

M

4

no

26

598

21

47

0.6

no

no

  1. Abbreviations: M: male; F: female; GBP: glycerol phenylbutyrate